Generated by GPT-5-mini| AMP | |
|---|---|
| Name | Adenosine monophosphate |
| Caption | Structural formula of adenosine monophosphate |
| Othernames | 5'-adenylic acid; AMP |
| Formula | C10H14N5O7P |
| Molar mass | 347.22 g·mol−1 |
AMP
Adenosine monophosphate is a nucleotide composed of an adenine base, a ribose sugar, and a single phosphate group; it participates broadly in cellular energy transfer, signal transduction, and nucleic acid metabolism. It functions as an intermediate in metabolic pathways, a regulator of enzymatic activity, and a precursor for nucleic acid synthesis across taxa from bacteria to mammals. Research into adenosine monophosphate spans biochemistry, physiology, clinical medicine, biotechnology, and industrial chemistry.
Adenosine monophosphate appears in canonical pathways such as glycolysis, oxidative phosphorylation, and purine metabolism and is studied in contexts including enzymology, mitochondrial function, and signal transduction. Investigators at institutions like the Max Planck Society, Harvard Medical School, Stanford University, University of Cambridge, and Massachusetts Institute of Technology have published work linking adenosine monophosphate to processes examined by researchers at the National Institutes of Health and the Wellcome Trust.
Chemically, adenosine monophosphate comprises an adenine nucleobase attached to a ribose sugar bearing a 5'-phosphate; this architecture is shared with other nucleotides such as guanosine monophosphate, cytidine monophosphate, and uridine monophosphate. It participates in phosphorylation-dephosphorylation cycles catalyzed by kinases and phosphatases, including enzymes from the E. coli purine biosynthesis operon and eukaryotic AMP-activated protein kinase pathways characterized in studies at Yale University and University College London. In aqueous solution, adenosine monophosphate exists in ionized forms influenced by pH and divalent cations such as magnesium. It can be synthesized de novo via the purine biosynthetic route involving intermediates studied by teams at the Salk Institute and converted from adenosine diphosphate and adenosine triphosphate through equilibria mediated by adenylate kinase, an enzyme researched at the Max Planck Institute for Biophysical Chemistry.
Adenosine monophosphate acts as a metabolic signal that interfaces with sensors like AMP-activated protein kinase and modulates downstream targets including transcription factors observed in experiments at Cold Spring Harbor Laboratory and The Scripps Research Institute. It contributes to nucleotide salvage pathways involving enzymes characterized by investigators at the European Molecular Biology Laboratory and supports ribonucleic acid synthesis within organelles such as mitochondria and chloroplasts that are subjects of study at the Smithsonian Institution and University of California, Berkeley. In microorganisms such as Saccharomyces cerevisiae and Bacillus subtilis, adenosine monophosphate levels influence regulatory networks governing stress responses and sporulation documented by researchers at Princeton University and University of Oxford. In multicellular animals, fluctuations in adenosine monophosphate modulate pathways implicated in energy homeostasis and adaptive responses investigated by teams at the Howard Hughes Medical Institute and Rockefeller University.
Altered adenosine monophosphate metabolism features in pathophysiology studied in clinical centers like Mayo Clinic and Cleveland Clinic, with implications for metabolic disorders, ischemia-reperfusion injury, and inherited enzyme deficiencies identified by geneticists at Columbia University and University of Pennsylvania. Pharmacological modulation of AMP-related signaling pathways underpins drug development efforts at pharmaceutical companies including Pfizer, Novartis, and GlaxoSmithKline and has been targeted in clinical trials overseen by regulators such as the U.S. Food and Drug Administration and European Medicines Agency. Biomarker research in oncology and cardiology involving nucleotide ratios employs platforms developed at Roche Diagnostics and Abbott Laboratories; diagnostic assays leveraging adenylate pools are used in specialist units at Johns Hopkins Hospital.
Adenosine monophosphate and its derivatives serve as reagents in molecular biology workflows implemented at laboratories like those of Illumina, Thermo Fisher Scientific, and Agilent Technologies for enzymatic ligation, polymerase reactions, and nucleic acid labeling. Bioprocessing operations at firms such as DSM and Merck Group utilize nucleotide chemistry for fermentation optimization and metabolic engineering in microorganisms including Corynebacterium glutamicum and Escherichia coli. In synthetic biology, nucleotide analogs and salvage pathways are engineered in platforms developed at Ginkgo Bioworks and Zymergen to produce value-added compounds. Materials science collaborations between groups at Massachusetts Institute of Technology and ETH Zurich have explored nucleotides as building blocks for nanostructures and hydrogels.
Foundational work on nucleotides emerged from studies by researchers such as Friedrich Miescher, who identified nucleic substances, and later chemists and physiologists who elucidated nucleotide structure and function. Contributions from laboratories of Arthur Kornberg, Severo Ochoa, and Har Gobind Khorana clarified enzymatic synthesis and the genetic code, while biochemists at Cambridge University and Karolinska Institutet advanced understanding of cellular energetics. Twentieth-century advances at institutes including the Rockefeller Institute and the Pasteur Institute established the centrality of nucleotides in metabolism, enzymology, and molecular genetics. Nobel Prize in Physiology or Medicine laureates associated with nucleotide research catalyzed translational and clinical developments that continue to shape modern biomedical science.
Category:Nucleotides